Pharmaceutical Processing World

Time 2021-05-27 23:12:36

Web Name: Pharmaceutical Processing World

WebSite: http://www.pharmpro.com

ID:179577

Keywords:

Pharmaceutical,Processing,World,

Description:

Pharmaceutical ProcessingFacilitySupply ChainEnterprise TechnologyContract ManufacturingR D 100 AwardsHouse report accuses AbbVie of price gougingNovatek requalified as a supplier for Boehringer Ingelheim s aseptic manufacturing facilities10 of the best pharma companies to work forWHO: All countries should vaccinate at least 10% of their people against COVID-19 by SeptemberPfizer explores combining COVID-19 vaccine with pneumococcal conjugate vaccineAurobindo wins FDA approval for dorzolamide HCl and timolol maleate ophthalmic solutionBD to build $200M facility in Spain for pre-filled drug delivery device manufacturingUK to accelerate COVID-19 vaccination based on Indian variant fearsInsulet sues Roche over diabetes tech patentToday on Pharmaceutical Processing By Brian Buntz | May 26, 2021House report accuses AbbVie of price gougingA recent report from the House Oversight and Reform Committee concluded that AbbVie (NYSE:ABBV) aggressively increased prices of popular drugs, including the bestseller Humira (adalimumab), which brought in close to $20 billion last year. Approximately $16 billion of those sales were in the U.S. In recent years, the company also repeatedly increased the price of By Brian Buntz | May 26, 2021Novatek requalified as a supplier for Boehringer Ingelheim s aseptic manufacturing facilitiesEnvironmental monitoring software developer Novatek (Quebec, Canada) has extended its partnership with Boehringer Ingelheim. In particular, Novatek has announced that it has won reapproval from the drugmaker to use its software in its human pharma, animal health and biopharmaceutical aseptic (sterile) manufacturing sites internationally. “We are excited to announce that Novatek is requalified as an approved supplier By Brian Buntz | May 26, 202110 of the best pharma companies to work forThe pharmaceutical industry is on the upswing and is poised to have a compound annual growth rate of 13.7% from 2020 to 2027, according to projections from Grand View Research. The industry’s resurgence is a good opportunity for employees in the sector, who frequently enjoy comfortable salaries. To get a sense of which pharmaceutical companies Read All Articles >Sponsored Content See More >Noble expands its services for its clients into Human FactorsHuman Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug Regulatory See More >House report accuses AbbVie of price gougingA recent report from the House Oversight and Reform Committee concluded that AbbVie (NYSE:ABBV) aggressively increased prices of popular drugs, including the bestseller Humira (adalimumab), which brought in close to $20 billion last year. Approximately $16 billion of those sales were in the U.S. In recent years, the company also repeatedly increased the price of Aurobindo wins FDA approval for dorzolamide HCl and timolol maleate ophthalmic solutionCanadian federal advisory committee prefers mRNA COVID-19 vaccines FDA hits Acceleron Pharma with notice of noncomplianceBiogen Q1 earnings beat estimates, raises EPS guidance Facility See More >Johnson Johnson COVID-19 vaccine shipments plungeJohnson Johnson will cut COVID-19 vaccine shipments by 86% in the coming week, according to CDC projections. The week of April 5, the company shipped nearly 5 million doses. Next week, that figure could fall to approximately 700,000.  The company anticipates that it can eventually deliver up to 8 million doses weekly, assuming FDA authorizes These technologies are speeding COVID-19 vaccines to marketWhy pharmaceutical companies are warming up to predictive maintenanceWhistleblower: FDA downplayed safety issues at Merck vaccine plantBioNTech wins EMA nod for COVID-19 vaccine site in GermanySupply Chain See More >BREAKING: Biden administration calls for waiving IP protections for COVID-19 vaccinesU.S. Trade Representative Katherine Tai announced this afternoon that the Biden administration supports waiving IP protections for COVID-19 vaccines. This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures, Tai said in the statement. Tai said the U.S. will actively participate in World Trade Organization text-based negotiations More than 5 million skipped getting second COVID-19 vaccine doseHow end-to-end visibility and machine learning can safeguard the vaccine supply chainJohnson Johnson COVID-19 vaccine shipments plungeEmergent reportedly had serious problems at Baltimore vaccine plantRecalls See More >GSK, Pfizer and J J among the most-fined drug companies, according to studyGlaxoSmithKline (LON:GSK) paid nearly $10 billion in inflation-adjusted financial penalties between January 2003 and December 2016, the highest tally for any drug company, according to research published in JAMA. That sum was more than any other in a sampling of 26 companies paying fines inside the U.S. Pfizer (NYSE: PFE) was next in line with Nostrum Laboratories recalls Type 2 diabetes drug over contamination problemsFlu vaccination worries rise in South Korea following deathsTorrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium TabletsLatex Hazard Leads to Recall of Certain Dyural-40 and Dyural-80 Convenience Kits DeviceTalks TuesdaysMEDTECH 100 INDEX The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.We Deliver!Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.

TAGS:Pharmaceutical Processing World 

<<< Thank you for your visit >>>

Hot Websites